Spinocerebellar ataxia type 27B (SCA27B), caused by an intronic GAA repeat expansion in the FGF14 gene, has recently emerged as a major cause of late-onset cerebellar ataxia (LOCA). Its prevalence and clinical profile in Central and Eastern Europe remain largely unknown. To determine the frequency and phenotypic characteristics of FGF14 GAA·TTC repeat expansions, a large cohort of Polish patients with undiagnosed adult-onset cerebellar ataxia was investigated. We retrospectively analyzed 701 patients (age of onset ≥ 25 years) with adult-onset cerebellar ataxia of unknown etiology, previously tested negative for SCA1, SCA2, SCA3, SCA8, and RFC1 expansions. GAA·TTC repeat lengths were assessed using long-range and repeat-primed PCR. Expansions ≥ 250 repeats were classified as pathogenic. Clinical and MRI data were evaluated where available. A control group of 66 neurologically healthy individuals was also screened. Pathogenic FGF14 expansions (≥ 250 repeats) were identified in 4.4
Aim. Patient rights are a set of rights granted to healthcare recipients. They include objective standards which inform patients about what they can expect from public authorities and institutions directly providing healthcare services. The main objective of the study was to assess the knowledge of physicians employed in public healthcare facilities about patient rights. Material and methods. The study was conducted in the period between October 2022 and March 2023. The diagnostic survey method was employed, using a self-developed questionnaire. One hundred respondents employed in hospitals and primary health-care facilities took part in the study. Microsoft Excel (Microsoft Office) was used to compile the data. The statistical analysis was conducted with the use of the Statistica 13.1 PL statistical software. Results. 61% of physicians reported their knowledge of patient rights to be satisfactory, while 39% found it unsatisfactory. 33% of respondents were familiarized with patient rights in the course of their higher education, while 67% learned about them only in the workplace. Meanwhile, 51% of respondents were familiar with the Patient Rights and the Patient Rights Ombudsman Act. 79% indicated that they complied with patient rights in their professional practice, while 33% of respondents confirmed that they had witnessed violations of patient rights in their workplace. Conclusions. Based on research, it can be concluded that there is a need to develop and implement a training program for medical personnel on patients’ rights. Doctors’ lack of knowledge about patients’ rights influences the exercise or violation of these rights.
Medicinal mushrooms have become an important component of modern dietary supplementation and functional nutrition due to their diverse biological activities and long-standing use in traditional medicine. Among the most widely studied and utilized species are Ganoderma lucidum, Lentinula edodes, Grifola frondosa, Cordyceps militaris, Cordyceps sinensis, Trametes versicolor, and Inonotus obliquus. Their therapeutic potential is associated with a wide range of biologically active constituents, including polysaccharides, triterpenoids, phenolic compounds, and other secondary metabolites. Experimental and clinical studies indicate that extracts derived from these species may support immune function, modulate inflammatory responses, and exhibit antioxidant, antimicrobial, and anticancer properties. In addition to extensive in vitro and in vivo investigations, a growing number of clinical studies have evaluated the safety and potential therapeutic benefits of medicinal mushroom preparations in humans. In recent years, increasing attention has been directed toward their incorporation into nutraceutical formulations and functional foods aimed at supporting health and preventing chronic diseases. Advances in cultivation technologies and extraction methods have also contributed to improved availability and standardization of mushroom-derived products. This review provides a comprehensive overview of selected medicinal mushroom species commonly used in dietary supplements, focusing on their bioactive constituents, reported biological activities, and potential applications in contemporary medicine.
Background Auditory verbal hallucinations (AVHs) are common and distressing symptoms across a range of psychiatric disorders, including schizophrenia spectrum disorders. Audio Visual Assisted Therapy Aid for Refractory Auditory Hallucinations (AVATAR) is an innovative therapeutic approach that facilitates dialogue with a digital avatar representing the voices that patients hear. Aims This systematic review and meta-analysis aimed to assess the efficacy, tolerability and acceptability of AVATAR therapy in reducing voice-related symptoms. Method Following preregistration, we conducted a systematic review and meta-analysis of controlled trials of AVATAR therapy in samples primarily diagnosed with schizophrenia spectrum disorders. PubMed, CINAHL, Embase, PsycInfo, ClinicalTrials.gov, ISRCTN and Web of Science were searched in March 2025. We assessed bias and certainty with the Cochrane Risk-of-Bias 2 tool and the GRADE approach. Random-effects models were used to synthesise outcomes. Results Eight AVATAR trials (N = 978) were included. Compared with usual treatment, waitlist and active control groups, AVATAR therapy decreased the primary outcome of AVH severity at post-treatment (Hedges’ g = −0.40, 95% CI −0.54 to −0.25) and short-term follow-up (Hedges’ g = −0.25, 95% CI −0.40 to −0.10). AVH subscales showed small significant effect sizes at post-treatment (frequency: Hedges’ g = −0.38, 95% CI −0.52 to −0.24; distress: Hedges’ g = −0.32, 95% CI −0.46 to −0.18), which were maintained at short-term follow-up. The certainty of evidence was rated moderate for AVH severity at post-treatment. AVATAR therapy was largely tolerable and acceptable, with adverse events mostly unrelated to the treatment and a comparable drop-out rate to control groups. Conclusions Findings suggest that AVATAR therapy is effective at reducing AVH symptoms. Considering heterogeneous control groups and less clear evidence for secondary outcomes and longer follow-ups, further research is warranted.
The aim of this article is to develop in detail the concept of criminal hypnosis, analysing its application in the legal context and proposing the formal recognition of hypnosis as a possible way of committing a crime. The work in question can be divided into six parts. The first part presents the genesis of hypnosis and defines its concept. The second part consists of a description of experimental studies aimed at demonstrating the possibility of committing crimes under the influence of hypnosis. The third part focuses on real cases that were the subject of the proceedings. The fourth part moves on to considerations on the recognition of hypnosis as a circumstance excluding guilt by analyzing the issue of mental coercion and insanity. Then, the classification of crimes committed under the influence of hypnosis was made depending on the sovereignty of the will of the hypnotized person, thus analyzing the possibility of assigning criminal liability to the hypnotist and the person who committed socially dangerous acts under the influence of hypnosis. The fifth part details the problem of non-experts dealing with hypnosis and proposes to designate a group of people authorized to use hypnosis, including the need to obtain an appropriate license. The last part presents conclusions and postulates resulting from the analysis.